Bio-Techne Corporation (TECH)
TECH · Health Care · 
United States
Bio-Techne Corporation (TECH) is a US company in the Health Care sector. The stock has its largest weight in XDEW (S&P 500 Equal Weight), at 0.20%. Anyone who holds an ETF containing Bio-Techne Corporation also has an indirect stake in the company.
Data and Charts: Bio-Techne Corporation
Key Data for Bio-Techne Corporation
Bio-Techne Corporation Stock Price Chart
The Bio-Techne Corporation chart shows daily closing prices and is set to the current year by default. The stock is up 23.6% year to date and up 19.2% over twelve months. The last recorded close on October 30, 2026, was $72.66, at 100% of the 52-week range.
Price series from our database since Aug 12, 2024, 558 daily values.
Bio-Techne Corporation Stock Performance
| Year to date | +23.6% | 1 year | +19.2% |
|---|---|---|---|
| 1 month | +0.3% | 3 months | +0.8% |
| Calendar year 2025 | -18.4% |
Measured in euros, Bio-Techne Corporation is up 29.9% year to date and up 23.2% over twelve months. The difference from the dollar figures above comes from the exchange rate alone. Each daily price is converted at the ECB euro reference rate for that day.
Alysly Data Analysis: Bio-Techne Corporation
What ETF Is Bio-Techne Corporation In?
Bio-Techne Corporation has average ETF coverage and is held by 11 of the 104 ETFs we track, which together follow 5 indices. That puts the stock in more ETFs than 68.1% of the 4,341 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| XDEW | S&P 500 Equal Weight | 0.20% | €1.96 |
| XSWC / XSWD | MSCI World Small Cap | 0.11% | €1.09 |
| ZPRS / WDSD | MSCI World Small Cap | 0.10% | €1.03 |
| SXR8 | S&P 500 | 0.02% | €0.20 |
| SPYL / SPY5 | S&P 500 | 0.02% | €0.18 |
| WIMI | MSCI World IMI | 0.01% | €0.11 |
| SPYI / SPSA | MSCI ACWI IMI | < 0.01% | < €0.05 |
The last column shows how much of €1,000 in one of these funds goes to Bio-Techne Corporation, based on each fund's latest holdings list.
US-listed ETFs holding Bio-Techne Corporation (weight per latest SEC filing): ONEQ 0.03%, IVV 0.02%, SPY 0.02%, VOO 0.02%, VTI 0.02%. These funds are registered in the US; retail investors in the EU usually cannot buy them.
Bio-Techne Corporation Weight in iShares Core S&P 500 (SXR8) Since 2021
In iShares Core S&P 500 (SXR8), Bio-Techne Corporation had a weight of 0.05% on Sep 30, 2021 and 0.02% on Oct 30, 2026. The fund tracks the S&P 500. Its share peaked at 0.05% on Sep 30, 2021. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.
What's Inside Your ETF Portfolio and the ETF overlap check show how much Bio-Techne Corporation overlaps with the rest of a portfolio.
Which Tracked Investors Hold Bio-Techne Corporation?
Bio-Techne Corporation is not among the largest purchases in the quarter ending Jun 30, 2026. The list is led by GOOGL, DAL and NEBIUS GROUP N.V. Of the 2 tracked managers holding the stock, 2 added.
| Investor | Shares | Value | Quarter |
|---|---|---|---|
| Soros Fund Management | 535,400 | $38M | newly added |
| Bridgewater Associates | 26,750 | $2M | increased by 20,773 |
As of Jun 30, 2026. Based on quarterly filings with the US securities regulator, submitted up to 45 days after the reference date. The change counts shares, not price gains.
Stocks With ETF Exposure Similar to Bio-Techne Corporation
| Stock | Shared ETFs | r | 1 year | Annualized volatility | Net margin | Revenue growth |
|---|---|---|---|---|---|---|
| Bio-Techne Corporation | – | – | +19.2% | 42.5% | 15.0% | -0.4% |
| Align Technology | 11 | – | +8.3% | 45.9% | 10.2% | +0.9% |
| Baxter International | 11 | – | +20.0% | 40.8% | -8.5% | +5.7% |
| DaVita | 11 | – | +57.9% | 38.9% | 5.5% | +6.5% |
| Henry Schein | 11 | – | +34.9% | 26.4% | 3.0% | +4.0% |
| Insulet Corporation | 11 | – | -52.0% | 40.8% | 9.1% | +30.7% |
| Revvity | 11 | +0.34 | +72.5% | 37.1% | 8.4% | +3.7% |
| Solventum Corporation | 11 | – | +17.4% | 29.8% | 18.7% | +0.9% |
 Universal Health Services | 11 | – | -19.5% | 32.6% | 8.6% | +9.7% |
These stocks reach a portfolio through largely the same funds as Bio-Techne Corporation. “Shared ETFs” counts the funds that hold both.
Return and volatility are calculated from our daily closing prices in US dollars. Margin and growth come from each company's latest SEC annual filing. Because fiscal years do not end on the same date for every company, the underlying periods are not fully identical.
Fundamental Analysis: Bio-Techne Corporation
Bio-Techne Corporation Key Financials
Figures come from the SEC annual filing for the latest reported fiscal year (period end Jun 30, 2026).
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| FY ended Jun 2023 | 1.1 | 0.3 | 25.1% |
| FY ended Jun 2024 | 1.2 | 0.2 | 14.5% |
| FY ended Jun 2025 | 1.2 | 0.1 | 6.0% |
| FY ended Jun 2026 | 1.2 | 0.2 | 15.0% |
Technical Analysis: Bio-Techne Corporation
Bio-Techne Corporation Risk Metrics
The close on Oct 30, 2026, was 9.6% below the highest close since Aug 12, 2024. That high was reached on Sep 19, 2024. When the S&P 500 rose or fell 1%, Bio-Techne Corporation moved 0.76% on average in the same direction (past 252 trading days). The correlation of 0.23, however, shows only a moderate link to the broad market. Accordingly, moves in the S&P 500 explain only a small part of the daily price moves of Bio-Techne Corporation.
What Bio-Techne Corporation Correlates With
| Instrument | r | −1 … +1 |
|---|---|---|
| HEI | +0.38 | |
| HYPE | +0.35 | |
| Revvity Inc. | +0.34 | |
| Micron Technology Inc. | +0.33 | |
| G | +0.33 | |
| ATM | +0.33 | |
| SNX | -0.54 | |
| TJX | -0.40 | |
| Ross Stores Inc. | -0.37 |
The strongest co-movers are listed at the top, the strongest inverse movers at the bottom. Low or negative correlations can help spread risk more broadly across a portfolio.
